User login
Article Type
Changed
Tue, 10/29/2024 - 12:08
Display Headline
Pulmonary Hypertension: Comorbidities and Novel Therapeutics
References
- Cullivan S, Gaine S, Sitbon O. New trends in pulmonary hypertension. Eur Respir Rev. 2023;32(167):220211. doi:10.1183/16000617.0211-2022
- Mocumbi A, Humbert M, Saxena A, et al. Pulmonary hypertension [published correction appears in Nat Rev Dis Primers. 2024;10(1):5]. Nat Rev Dis Primers. 2024;10(1):1. doi:10.1038/s41572-023-00486-7
- Lang IM, Palazzini M. The burden of comorbidities in pulmonary arterial hypertension. Eur Heart J Suppl. 2019;21(suppl K):K21-K28. doi:10.1093/ eurheartj/suz205
- Yan L, Zhao Z, Zhao Q, et al. The clinical characteristics of patients with pulmonary hypertension combined with obstructive sleep apnoea. BMC Pulm Med. 2021;21(1):378. doi:10.1186/s12890-021-01755-5
- Hoeper MM, Badesch DB, Ghofrani HA, et al; for the STELLAR Trial Investigators. Phase 3 trial of sotatercept for treatment of pulmonary arterial hypertension. N Engl J Med. 2023;388(16):1478-1490. doi:10.1056/NEJMoa2213558
- Grünig E, Jansa P, Fan F, et al. Randomized trial of macitentan/tadalafil single-tablet combination therapy for pulmonary arterial hypertension. J Am Coll Cardiol. 2024;83(4):473-484. doi:10.1016/j.jacc.2023.10.045
- Higuchi S, Horinouchi H, Aoki T, et al. Balloon pulmonary angioplasty in the management of chronic thromboembolic pulmonary hypertension. Radiographics. 2022;42(6):1881-1896. doi:10.1148/rg.210102
Publications
References
- Cullivan S, Gaine S, Sitbon O. New trends in pulmonary hypertension. Eur Respir Rev. 2023;32(167):220211. doi:10.1183/16000617.0211-2022
- Mocumbi A, Humbert M, Saxena A, et al. Pulmonary hypertension [published correction appears in Nat Rev Dis Primers. 2024;10(1):5]. Nat Rev Dis Primers. 2024;10(1):1. doi:10.1038/s41572-023-00486-7
- Lang IM, Palazzini M. The burden of comorbidities in pulmonary arterial hypertension. Eur Heart J Suppl. 2019;21(suppl K):K21-K28. doi:10.1093/ eurheartj/suz205
- Yan L, Zhao Z, Zhao Q, et al. The clinical characteristics of patients with pulmonary hypertension combined with obstructive sleep apnoea. BMC Pulm Med. 2021;21(1):378. doi:10.1186/s12890-021-01755-5
- Hoeper MM, Badesch DB, Ghofrani HA, et al; for the STELLAR Trial Investigators. Phase 3 trial of sotatercept for treatment of pulmonary arterial hypertension. N Engl J Med. 2023;388(16):1478-1490. doi:10.1056/NEJMoa2213558
- Grünig E, Jansa P, Fan F, et al. Randomized trial of macitentan/tadalafil single-tablet combination therapy for pulmonary arterial hypertension. J Am Coll Cardiol. 2024;83(4):473-484. doi:10.1016/j.jacc.2023.10.045
- Higuchi S, Horinouchi H, Aoki T, et al. Balloon pulmonary angioplasty in the management of chronic thromboembolic pulmonary hypertension. Radiographics. 2022;42(6):1881-1896. doi:10.1148/rg.210102
References
- Cullivan S, Gaine S, Sitbon O. New trends in pulmonary hypertension. Eur Respir Rev. 2023;32(167):220211. doi:10.1183/16000617.0211-2022
- Mocumbi A, Humbert M, Saxena A, et al. Pulmonary hypertension [published correction appears in Nat Rev Dis Primers. 2024;10(1):5]. Nat Rev Dis Primers. 2024;10(1):1. doi:10.1038/s41572-023-00486-7
- Lang IM, Palazzini M. The burden of comorbidities in pulmonary arterial hypertension. Eur Heart J Suppl. 2019;21(suppl K):K21-K28. doi:10.1093/ eurheartj/suz205
- Yan L, Zhao Z, Zhao Q, et al. The clinical characteristics of patients with pulmonary hypertension combined with obstructive sleep apnoea. BMC Pulm Med. 2021;21(1):378. doi:10.1186/s12890-021-01755-5
- Hoeper MM, Badesch DB, Ghofrani HA, et al; for the STELLAR Trial Investigators. Phase 3 trial of sotatercept for treatment of pulmonary arterial hypertension. N Engl J Med. 2023;388(16):1478-1490. doi:10.1056/NEJMoa2213558
- Grünig E, Jansa P, Fan F, et al. Randomized trial of macitentan/tadalafil single-tablet combination therapy for pulmonary arterial hypertension. J Am Coll Cardiol. 2024;83(4):473-484. doi:10.1016/j.jacc.2023.10.045
- Higuchi S, Horinouchi H, Aoki T, et al. Balloon pulmonary angioplasty in the management of chronic thromboembolic pulmonary hypertension. Radiographics. 2022;42(6):1881-1896. doi:10.1148/rg.210102
Publications
Publications
Article Type
Display Headline
Pulmonary Hypertension: Comorbidities and Novel Therapeutics
Display Headline
Pulmonary Hypertension: Comorbidities and Novel Therapeutics
Disallow All Ads
Content Gating
Open Access (article Unlocked/Open Access)
Alternative CME
Disqus Comments
Default
Eyebrow Default
SLIDESHOW
Consolidated Pubs: Do Not Show Source Publication Logo
Use ProPublica
Conference Recap Checkbox
Not Conference Recap
Clinical Edge
Medscape Article
Display survey writer
Reuters content
Disable Inline Native ads
WebMD Article